New research presented at the European Congress on Obesity (ECO 2026) in Istanbul, Turkey (12–15 May) and published in The Lancet shows that people who have lost weight using the maximum tolerated ...

The weight-loss race ramped up this summer as two new tablet formats from the makers of Ozempic and Mounjaro hit the market.

In SURMOUNT-MAINTAIN, participants switching to a 5mg maintenance dose of tirzepatide experienced a mean weight change of 5.6 kg over 52 weeks, following an initial 60-week weight-loss period. Oral ...

Kailera Therapeutics initiated with a Hold rating due to efficacy data released and long timelines for key catalysts. Click for key KLRA catalysts and risks.

If you’re on a weight loss journey, it can be easy to look for instant results – but the most successful weight loss journeys are rarely dramatic… One of the biggest problems in weight loss today is ...

Limiting meals to a set period each day has become a popular way to manage weight. A new Johns Hopkins Medicine study ...

Retatrutide met primary and key secondary endpoints in a 2339-participant, randomized, double-blind, placebo-controlled phase 3 trial, demonstrating clinically meaningful weight reduction across 4, 9, ...

"By contrast, we show that rapid weight loss is not associated with weight regain, and, more importantly, that a larger proportion of participants undergoing rapid weight loss—compared with gradual ...

If you’ve been a victim of weight-loss gimmicks, you know no amount of fad diets and trendy workouts will help you lose weight and keep it off. The endless cycle of losing and re-gaining only stops ...